Profile | GDS5420 / 233946_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 261.59 | 56 |
GSM1296119 | B_lesional_pre-dose | 296.53 | 59 |
GSM1296076 | C_lesional_pre-dose | 514.57 | 69 |
GSM1296092 | D_lesional_pre-dose | 338.51 | 62 |
GSM1296103 | E_lesional_pre-dose | 329.73 | 61 |
GSM1296078 | F_lesional_pre-dose | 558.48 | 70 |
GSM1296107 | G_lesional_pre-dose | 333.14 | 61 |
GSM1296109 | H_lesional_pre-dose | 243.13 | 54 |
GSM1296080 | I_lesional_pre-dose | 251.49 | 57 |
GSM1296090 | J_lesional_pre-dose | 302.18 | 60 |
GSM1296074 | K_lesional_pre-dose | 347.81 | 63 |
GSM1296111 | L_lesional_pre-dose | 409.04 | 64 |
GSM1296099 | M_lesional_pre-dose | 193.74 | 52 |
GSM1296086 | O_lesional_pre-dose | 310.74 | 61 |
GSM1296117 | P_lesional_pre-dose | 394.75 | 63 |
GSM1296113 | Q_lesional_pre-dose | 343 | 60 |
GSM1296096 | R_lesional_pre-dose | 221.5 | 54 |
GSM1296105 | S_lesional_pre-dose | 352.57 | 61 |
GSM1296098 | T_lesional_pre-dose | 212.31 | 53 |
GSM1296101 | U_lesional_pre-dose | 315.17 | 59 |
GSM1296121 | V_lesional_pre-dose | 238.34 | 55 |
GSM1296088 | W_lesional_pre-dose | 342.68 | 62 |
GSM1296082 | X_lesional_pre-dose | 195.64 | 54 |
GSM1296115 | Y_lesional_pre-dose | 361.64 | 62 |
GSM1296084 | Z_lesional_pre-dose | 363.93 | 62 |
GSM1296072 | B_lesional_day8 | 319.63 | 60 |
GSM1296069 | L_lesional_day8 | 388.82 | 63 |
GSM1296071 | P_lesional_day8 | 313.92 | 59 |
GSM1296070 | Y_lesional_day8 | 401.89 | 63 |
GSM1296073 | V_lesional_day8 | 336.2 | 61 |
GSM1296034 | A_lesional_day15 | 237.19 | 54 |
GSM1296041 | G_lesional_day15 | 348.03 | 62 |
GSM1296035 | R_lesional_day15 | 212.44 | 54 |
GSM1296038 | U_lesional_day15 | 363.95 | 62 |
GSM1296047 | B_lesional_day15 | 331.97 | 60 |
GSM1296039 | E_lesional_day15 | 260.7 | 57 |
GSM1296042 | H_lesional_day15 | 383.9 | 63 |
GSM1296043 | L_lesional_day15 | 417.94 | 64 |
GSM1296037 | M_lesional_day15 | 282.15 | 58 |
GSM1296046 | P_lesional_day15 | 428.12 | 64 |
GSM1296044 | Q_lesional_day15 | 415.03 | 64 |
GSM1296045 | Y_lesional_day15 | 435.51 | 65 |
GSM1296025 | C_lesional_day15 | 332.15 | 61 |
GSM1296033 | D_lesional_day15 | 376.67 | 63 |
GSM1296027 | I_lesional_day15 | 377.56 | 64 |
GSM1296032 | J_lesional_day15 | 352.57 | 61 |
GSM1296024 | K_lesional_day15 | 311.11 | 60 |
GSM1296031 | W_lesional_day15 | 325.38 | 60 |
GSM1296028 | X_lesional_day15 | 220.84 | 54 |
GSM1296029 | Z_lesional_day15 | 307.85 | 59 |
GSM1296026 | F_lesional_day15 | 405.99 | 65 |
GSM1296030 | O_lesional_day15 | 385.81 | 64 |
GSM1296040 | S_lesional_day15 | 272.74 | 57 |
GSM1296036 | T_lesional_day15 | 313.7 | 59 |
GSM1296048 | V_lesional_day15 | 322.82 | 60 |
GSM1296059 | A_lesional_day43 | 287.39 | 59 |
GSM1296066 | G_lesional_day43 | 452.75 | 66 |
GSM1296060 | R_lesional_day43 | 207.39 | 53 |
GSM1296063 | U_lesional_day43 | 466.54 | 67 |
GSM1296064 | E_lesional_day43 | 373.68 | 63 |
GSM1296067 | H_lesional_day43 | 314.82 | 58 |
GSM1296062 | M_lesional_day43 | 225.7 | 54 |
GSM1296068 | Q_lesional_day43 | 382.06 | 62 |
GSM1296050 | C_lesional_day43 | 433.48 | 66 |
GSM1296057 | D_lesional_day43 | 247.28 | 56 |
GSM1296052 | I_lesional_day43 | 346.84 | 62 |
GSM1296054 | J_lesional_day43 | 242.31 | 55 |
GSM1296049 | K_lesional_day43 | 313.49 | 60 |
GSM1296055 | W_lesional_day43 | 322.03 | 60 |
GSM1296053 | X_lesional_day43 | 267.57 | 57 |
GSM1296058 | Z_lesional_day43 | 206.43 | 53 |
GSM1296051 | F_lesional_day43 | 455.77 | 67 |
GSM1296056 | O_lesional_day43 | 207.57 | 54 |
GSM1296065 | S_lesional_day43 | 369.87 | 62 |
GSM1296061 | T_lesional_day43 | 234.56 | 55 |
GSM1296095 | A_non-lesional_pre-dose | 363.08 | 63 |
GSM1296120 | B_non-lesional_pre-dose | 292.47 | 58 |
GSM1296077 | C_non-lesional_pre-dose | 326.39 | 61 |
GSM1296093 | D_non-lesional_pre-dose | 215.81 | 53 |
GSM1296104 | E_non-lesional_pre-dose | 242.96 | 55 |
GSM1296079 | F_non-lesional_pre-dose | 457.79 | 67 |
GSM1296108 | G_non-lesional_pre-dose | 389.22 | 63 |
GSM1296110 | H_non-lesional_pre-dose | 405.72 | 63 |
GSM1296081 | I_non-lesional_pre-dose | 296.24 | 60 |
GSM1296091 | J_non-lesional_pre-dose | 318.62 | 61 |
GSM1296075 | K_non-lesional_pre-dose | 429.56 | 66 |
GSM1296112 | L_non-lesional_pre-dose | 457.82 | 65 |
GSM1296100 | M_non-lesional_pre-dose | 155.78 | 47 |
GSM1296087 | O_non-lesional_pre-dose | 469.42 | 67 |
GSM1296118 | P_non-lesional_pre-dose | 402.21 | 63 |
GSM1296114 | Q_non-lesional_pre-dose | 423.6 | 64 |
GSM1296097 | R_non-lesional_pre-dose | 202.54 | 52 |
GSM1296106 | S_non-lesional_pre-dose | 282.69 | 57 |
GSM1296102 | U_non-lesional_pre-dose | 234.49 | 54 |
GSM1296122 | V_non-lesional_pre-dose | 237.47 | 54 |
GSM1296089 | W_non-lesional_pre-dose | 487.15 | 67 |
GSM1296083 | X_non-lesional_pre-dose | 228.86 | 54 |
GSM1296116 | Y_non-lesional_pre-dose | 477.89 | 66 |
GSM1296085 | Z_non-lesional_pre-dose | 375.79 | 63 |